EGFR and non-small cell lung carcinoma: The purpose was to discuss the incidence of BMs, molecular characteristics of EGFR mutation, clinical and imaging characteristics of BMs, brain surveillance strategies, influence of treatments on BMs, and prognosis after BMs among NSCLC patients, which allows us to better understand the association between EGFR mutations and BMs, inform clinical practice, and help manage brain metastases.